<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0034-7418</journal-id>
<journal-title><![CDATA[Revista Colombiana de Ciencias Químico - Farmacéuticas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. colomb. cienc. quim. farm.]]></abbrev-journal-title>
<issn>0034-7418</issn>
<publisher>
<publisher-name><![CDATA[Departamento de Farmácia, Facultad de Ciencias, Universidade Nacional da Colombia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0034-74182018000200151</article-id>
<article-id pub-id-type="doi">10.15446/rcciquifa.v47n2.73964</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Percepción de usuarios de Cali-Colombia acerca de medicamentos genéricos]]></article-title>
<article-title xml:lang="en"><![CDATA[Perception of users of Cali-Colombia about generic medicines]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Torres Serna]]></surname>
<given-names><![CDATA[Camilo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Altman Salcedo]]></surname>
<given-names><![CDATA[David]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fernández Rodríguez]]></surname>
<given-names><![CDATA[Luisa María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Orozco Idrobo]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rosero Alayón]]></surname>
<given-names><![CDATA[Rodrigo A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Libre Escuela de Medicina ]]></institution>
<addr-line><![CDATA[Santiago de Cali ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2018</year>
</pub-date>
<volume>47</volume>
<numero>2</numero>
<fpage>151</fpage>
<lpage>168</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0034-74182018000200151&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0034-74182018000200151&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0034-74182018000200151&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN En la población en general existe gran controversia alrededor del uso de medicamentos innovadores y de sus copias llamadas medicamentos genéricos. El objetivo de este estudio es cuantificar la aceptación de los pacientes, del Sistema General de Seguridad Social en Salud de Colombia (SGSSS) a la prescripción de medicamentos genéricos. Se realizó un estudio de tipo descriptivo con un diseño transversal en 63 hombres y 57 mujeres, todos adultos pacientes que asistieron a consulta externa de los sitios de práctica de una Facultad de Medicina de Cali-Colombia. Se concluye que si se usan medicamentos genéricos, se requiere que los médicos y los usuarios tengan confianza en él. Los resultados del presente estudio muestran que, aunque no en forma mayoritaria, todavía un porcentaje importante de los consumidores entrevistados dudan de la calidad y de los resultados terapéuticos de los genéricos. De manera preocupante, casi una cuarta parte de los participantes en el estudio piensa que los medicamentos genéricos son productos fraudulentos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY In the general population, there is a great controversy surrounding the use of innovative drugs and their copies called generic drugs. The objective of this study is to quantify the acceptance of patients from the General System of Social Security in Health of Colombia (SGSSS) to the prescription of generic drugs. A descriptive study was carried out with a transversal design. The universe was 63 men and 57 women, all adult patients who attended external consultation of the practice sites of the Faculty of Medicine of Cali-Colombia. It is concluded that if generic drugs are used, it is necessary that doctors and users have confidence in it, the results of the present study show that, although not in the majority, still a significant percentage of the consumers interviewed doubt the quality and the therapeutic results of generics. Worryingly, nearly a quarter of study participants think that generic drugs are fraudulent products.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[prescripción de medicamentos]]></kwd>
<kwd lng="es"><![CDATA[medicamentos genéricos]]></kwd>
<kwd lng="es"><![CDATA[medicamentos innovadores]]></kwd>
<kwd lng="es"><![CDATA[medicamentos fraudulentos]]></kwd>
<kwd lng="en"><![CDATA[Prescription drugs]]></kwd>
<kwd lng="en"><![CDATA[generic drugs]]></kwd>
<kwd lng="en"><![CDATA[innovative drugs]]></kwd>
<kwd lng="en"><![CDATA[fraudulent drugs]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bolaños]]></surname>
<given-names><![CDATA[V.H.]]></given-names>
</name>
<name>
<surname><![CDATA[D'Alessio]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Fefer]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Joncheere]]></surname>
<given-names><![CDATA[K. de]]></given-names>
</name>
</person-group>
<source><![CDATA[rmonización de la reglamentación farmacéutica en América Latina]]></source>
<year>1996</year>
<publisher-loc><![CDATA[Washington, D. C ]]></publisher-loc>
<publisher-name><![CDATA[Organización Panamericana de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McLachlan]]></surname>
<given-names><![CDATA[A.J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frequently asked questions about generic medicines]]></article-title>
<source><![CDATA[Austr. Prescribes]]></source>
<year>2007</year>
<volume>30</volume>
<page-range>41-3</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>OMS</collab>
<source><![CDATA[Medicamentos esenciales]]></source>
<year>2007</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[Organización Mundial de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goldman]]></surname>
<given-names><![CDATA[D.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Joyce]]></surname>
<given-names><![CDATA[G.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Zheng]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prescription drug cost sharing]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2007</year>
<volume>298</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>61-9</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[A.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Martos]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Leiva]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez de la Cuesta]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genéricos: ¿buenos o malos? Conocimientos y actitudes de los médicos ante los medicamentos genéricos]]></article-title>
<source><![CDATA[Gaceta Sanit]]></source>
<year>2003</year>
<volume>17</volume>
<page-range>144-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Velásquez]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Pascale]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Globalización y acceso a los medicamentos: perspectivas sobre el acuerdo ADPIC/OMC]]></source>
<year>2000</year>
<edition>2</edition>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[Organización Mundial de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Action Programme on Essential Drugs]]></source>
<year>1997</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[Global comparative pharmaceutical expenditures]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<source><![CDATA[Mitos y verdades sobre medicamentos genéricos]]></source>
<year>2009</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Isaza]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Siete verdades sobre medicamentos genéricos en Colombia]]></source>
<year>2009</year>
<conf-name><![CDATA[ Primerforo nacional "La verdad sobre los medicamentos genéricos"]]></conf-name>
<conf-loc>Bogotá </conf-loc>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hendeles]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Hochhaus]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Kazerounian]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Generic and alternative brand-name pharmaceutical equivalents]]></article-title>
<source><![CDATA[Am. J. Hosp. Pharm]]></source>
<year>1993</year>
<volume>50</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>323-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[J.E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Generic substitution and optimal patient care]]></article-title>
<source><![CDATA[Arch. Intern. Med]]></source>
<year>1999</year>
<volume>159</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>429-33</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meredith]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bioequivalence and other unresolved issues in generic drug substitution]]></article-title>
<source><![CDATA[Clin. Ther]]></source>
<year>2003</year>
<volume>25</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2875-90</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vásquez-Serrano]]></surname>
<given-names><![CDATA[M.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Cortés-Gamba]]></surname>
<given-names><![CDATA[M.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Rossi-Buenaventura]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<source><![CDATA[Efectos de las marcas comerciales en medicamentos]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Ifarma]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<collab>OMS</collab>
<source><![CDATA[Medicamentos falsificados - Pautas para la formulación de medidas para combatir los medicamentos falsificados]]></source>
<year>1999</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meredith]]></surname>
<given-names><![CDATA[P.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Generic drugs: Therapeutic equivalence]]></article-title>
<source><![CDATA[Drug Saf]]></source>
<year>1996</year>
<volume>15</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>233-42</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meyer]]></surname>
<given-names><![CDATA[M.C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Generic drug product equivalence]]></article-title>
<source><![CDATA[Am. J. Manag. Care]]></source>
<year>1998</year>
<volume>4</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1183-92</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[J.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Holbrook]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Dolovich]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Are brand-name and generic warfarin interchangeable?]]></article-title>
<source><![CDATA[Ann. Pharmacother]]></source>
<year>2005</year>
<volume>39</volume>
<numero>7-8</numero>
<issue>7-8</issue>
<page-range>1188-93</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Verbeeck]]></surname>
<given-names><![CDATA[R.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Kanfer]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[R.B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Generic substitution: The use of medicinal products containing different salts and implications for safety and efficacy]]></article-title>
<source><![CDATA[Eur. J. Pharm. Sci]]></source>
<year>2006</year>
<volume>28</volume>
<numero>1-2</numero>
<issue>1-2</issue>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bhosle]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Sayyed]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Bhagat]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Shaikh]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Sheikh]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Bhopale]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Quazi]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of generic and branded drugs on cost effective and cost benefit analysis]]></article-title>
<source><![CDATA[Ann. Int. Med. Dental Res]]></source>
<year>2016</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>35-7</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<collab>Consumers' Association</collab>
<article-title xml:lang=""><![CDATA[Generic medicines: Can quality be assured?]]></article-title>
<source><![CDATA[Drug Ther. Bull]]></source>
<year>1997</year>
<volume>35</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>9-11</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaither]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Kirking]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Ascione]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Welage]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumers' views on generic medications]]></article-title>
<source><![CDATA[J. Am. Pharm. Assoc]]></source>
<year>2001</year>
<volume>41</volume>
<page-range>729-36</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Al-Jazairi]]></surname>
<given-names><![CDATA[A.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Bhareth]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Eqtefan]]></surname>
<given-names><![CDATA[I.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Suwayeh]]></surname>
<given-names><![CDATA[S.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Brand and generic medications: Are they interchangeable?]]></article-title>
<source><![CDATA[Ann. Saudi Med]]></source>
<year>2008</year>
<volume>28</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33-41</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davit]]></surname>
<given-names><![CDATA[B.N.]]></given-names>
</name>
<name>
<surname><![CDATA[Nwakama]]></surname>
<given-names><![CDATA[P.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Buehler]]></surname>
<given-names><![CDATA[G.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Conner]]></surname>
<given-names><![CDATA[D.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Haidar]]></surname>
<given-names><![CDATA[S.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[D.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[L.X.]]></given-names>
</name>
<name>
<surname><![CDATA[Woodcock]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparing generic and innovator drugs: A review of 12 years of bioequivalence data from the United States Food and Drug Administration]]></article-title>
<source><![CDATA[Ann. Pharmacother]]></source>
<year>2009</year>
<volume>43</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1583-97</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kesselheim]]></surname>
<given-names><![CDATA[A.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Misono]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[J.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Stedman]]></surname>
<given-names><![CDATA[M.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Brookhart]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Choudhry]]></surname>
<given-names><![CDATA[N.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Shrank]]></surname>
<given-names><![CDATA[W.H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical equivalence of generic and brand-name drugs used in cardiovascular disease. A systematic review and meta-analysis]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2008</year>
<volume>300</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>2514-26</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fischer]]></surname>
<given-names><![CDATA[M.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Avorn]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Potential savings from increased use of generic drugs in the elderly]]></article-title>
<source><![CDATA[Pharmacoepidemiol. Drug Saf]]></source>
<year>2004</year>
<volume>13</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>207-14</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calvert]]></surname>
<given-names><![CDATA[R.T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bioequivalence and generic prescribing]]></article-title>
<source><![CDATA[J. Pharm. Pharmacol]]></source>
<year>1996</year>
<volume>48</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>9-10</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shrank]]></surname>
<given-names><![CDATA[W.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Cox]]></surname>
<given-names><![CDATA[E.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Fischer]]></surname>
<given-names><![CDATA[M.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Choudhry]]></surname>
<given-names><![CDATA[N.K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patients' perceptions of generic medications]]></article-title>
<source><![CDATA[HealthAff. (Millwood)]]></source>
<year>2009</year>
<volume>28</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>546-56</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Strom]]></surname>
<given-names><![CDATA[B.L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Generic drug substitution revisited]]></article-title>
<source><![CDATA[New Engl. J. Med]]></source>
<year>1987</year>
<volume>316</volume>
<numero>23</numero>
<issue>23</issue>
<page-range>1456-62</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
